Iterum Therapeutics Plc (ITRM) Tops Q1 EPS by 5c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q1 EPS of ($0.10), $0.05 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• McEwen Copper seeks $1.6b in equity financing for Los Azules - Bloomberg
• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• SEC proposes new rules for crypto asset investment contracts